Lenardo M, Rustgi A K, Schievella A R, Bernards R
Whitehead Institute for Biomedical Research, Cambridge MA 02142.
EMBO J. 1989 Nov;8(11):3351-5. doi: 10.1002/j.1460-2075.1989.tb08497.x.
Amplification of the N-myc oncogene in human neuroblastoma is associated with increased metastatic ability. We previously found that over-expression of N-myc in rat neuroblastoma tumor cells causes a dramatic reduction in the expression of MHC class I mRNA. We show here that two distinct elements in the promoter render the MHC class I genes susceptible to N-myc-mediated suppression, one of which was identified as the MHC class I gene enhancer. Our data indicate that elevated N-myc expression is associated with reduced binding of a transcription factor that activates this enhancer. As a result, the activity of the MHC class I gene enhancer is greatly diminished. Elevated expression of the N-myc oncogene in human neuroblastomas and murine pre-B lymphoid lines also correlated with reduced factor binding to the MHC class I gene enhancer. Thus, an important effect of N-myc may be to impair the function of certain cellular enhancers by altering the levels of their cognate binding proteins.
人类神经母细胞瘤中N - myc癌基因的扩增与转移能力增强有关。我们之前发现,大鼠神经母细胞瘤肿瘤细胞中N - myc的过表达会导致MHC I类mRNA表达显著降低。我们在此表明,启动子中的两个不同元件使MHC I类基因易受N - myc介导的抑制,其中一个被鉴定为MHC I类基因增强子。我们的数据表明,N - myc表达升高与激活该增强子的转录因子结合减少有关。结果,MHC I类基因增强子的活性大大降低。人类神经母细胞瘤和小鼠前B淋巴细胞系中N - myc癌基因的高表达也与该因子与MHC I类基因增强子的结合减少相关。因此,N - myc的一个重要作用可能是通过改变其同源结合蛋白的水平来损害某些细胞增强子的功能。